메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

TCI Biotech Releases 2024 ESG Report, Showcasing Brand Transformation, Global Sustainability Commitments, and Award-Winning Impact

SALT LAKE CITY, Oct. 8, 2025 -- TCI Biotech, a global biotechnology leader in health and wellness, today announced the release of its 2024 Environmental, Social, and Governance (ESG) Report, marking a milestone year of brand renewal, international sustainability recognition, and measurable ESG results. Alongside the report, TCI announced top honors at the 2025 Green World Awards and the International CSR Excellence Awards, reaffirming its position as a global sustainability innovator serving 67 countries worldwide. Brand Renewal and Global Vision In 2025, TCI Biotech intr
- 김갑성 기자
- 2025-10-08 23:00
C-Ray Therapeutics (Shanghai) Co., Ltd. Presents Breakthrough Clinical Data of Novel Targeted Alpha Therapy 225Ac-PSMA-CY313 at EANM 2025

BARCELONA, Spain, Oct. 8, 2025 -- During the 2025 Annual Congress of the European Association of Nuclear Medicine (EANM 2025), C-Ray Therapeutics (Shanghai) Co., Ltd. ("C-Ray Shanghai"), a company dedicated to the development of innovative targeted radiopharmaceuticals, announced promising new clinical results for its lead program 225Ac-PSMA-CY313 in the treatment of metastatic castration-resistant prostate cancer (mCRPC). These data, highlighted in two Top Rated Oral Presentations, provide early clinical evidence of the therapy's significant potential and favorable s
- 김갑성 기자
- 2025-10-08 22:20
India's No: 1 Ranked Institute, IIT Madras & Danish University Study reveals Genetic 'Switches' that can transform Disease Research

CHENNAI, India, Oct. 8, 2025 -- India's No:1 Ranked Institute, the Indian Institute of Technology Madras, and Danish researchers have shown how interactions between genetic variants can act like 'switches' to unlock hidden cellular pathways. The findings of this research, undertaken jointly with the Technical University of Denmark, were published in a research paper in the prestigious, internationally-renowned Nature Communications journal (DOI: 10.1038/s41467-025-63306-4), an open-access journal also published by Springer Nature. In this study, the researchers, using sy
- 김갑성 기자
- 2025-10-08 21:48
NYSE Content Advisory: Pre-Market Update + The AW Playmaker Awards Take the Stage at 11 Wall Street

NEW YORK, Oct. 8, 2025 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market Update + The AW Playmaker Awards Take the Stage at 11 Wall Street Ashley Mastronardi delivers the pre-market update on October 8th Stocks are fractionally higher Wednesday as traders await minutes from the Federal Reserve's latest meeting. The gains come after the S&P 500 snapped a seven-day winning streak
- 황정호 기자
- 2025-10-08 21:20
Public Interest Registry Unveils Winners of 7th Annual .ORG Impact Awards at DC Ceremony Hosted by Grammy-Award Winning Artist Common

The Fund for Congolese Women named 2025 .ORG of the Year, selected from nearly 3,000 applicants from more than 120 countries WASHINGTON, Oct. 8, 2025 -- Public Interest Registry (PIR), the people behind the .ORG domain, announced the winners of the 2025 ORG Impact Awards, an annual celebration recognizing and rewarding outstanding mission-driven individuals and organizations from around the world for their positive contributions to society. The seven winners — selected from nearly 3,000 applicants from more than 120 countries — were announced live at the awards ceremony, which
- 김갑성 기자
- 2025-10-08 21:00
Alpha Fusion and Kobe City Medical Center General Hospital Establish At-211 Investigational Drug Supply System

〜Driving Technology Transfer and Test Manufacturing Following Regulatory Approval to Launch Company-Led af-001 Trial〜 TOKYO, Oct. 8, 2025 -- Alpha Fusion Inc. (Alpha Fusion) is proud to announce a joint initiative with the Kobe City Medical Center General Hospital (KCGH) to establish a domestic supply system for investigational drugs utilizing Astatine-211 (At-211). This collaboration significantly advances the foundational work for what is expected to be the world's first company-sponsored clinical trial using At-211 (as of September 2025). KCGH has secured usage approv
- 김갑성 기자
- 2025-10-08 21:00
POMDOCTOR LIMITED Announces Pricing of Initial Public Offering

GUANGZHOU, China, Oct. 8, 2025 -- POMDOCTOR LIMITED (the "Company" or "POMDOCTOR"), a leading online medical services platform for chronic diseases in China, today announced the pricing of its initial public offering (the "Offering") of 5,000,004 American Depositary Shares ("ADSs") at a public offering price of US$4.00 per ADS. Six ADSs represent one Class A ordinary share, par value US$0.0001 per share, of the Company. The ADSs have been approved for listing on the Nasdaq Global Market and are expected to commence trading on October 8, 2025 under the t
- 김갑성 기자
- 2025-10-08 20:00
AXA BetterMe Weekend Celebrates Fifth Anniversary

[ 메디채널 김갑성 기자 ] Championing holistic well-being and sustainable livingBuilding for a healthier future HONG KONG, Oct. 8, 2025 -- AXA Hong Kong and Macau (AXA) is excited to announce the return of its annual community event, the AXA BetterMe Weekend. Now in its fifth year, the carnival underscores AXA's commitment to promoting holistic well-being and advancing sustainable development within the community. This milestone edition will be held on 25 to 26 October (Saturday and Sunday) at AXA WONDERLAND, WestK, and feature AXA brand ambassador and award-winning actress and singer Sammi Ch
- 김갑성 기자
- 2025-10-08 17:10
BTL Files Patent Infringement Lawsuit Against WonderFace Device

PRAGUE, Oct. 8, 2025 -- BTL Group, a global leader in medical solutions, today announced that it has initiated an international patent infringement action before the Unified Patent Court against Lexter Microelectronic Engineering Systems S.L., the manufacturer of the WonderFace device. The lawsuit is based on BTL's patents related to its EMFACE® technology1. EMFACE® revolutionized facial lifting procedures by combining selective muscle stimulation with radiofrequency heating in distinct hands-free applicators, establishing an entirely new category of facial procedures.&
- 김갑성 기자
- 2025-10-08 16:14
Siemens Healthineers and National University Hospital Partner on Research to Advance Non-Invasive Liver Disease Diagnostics

Partnership will evaluate advanced ultrasound technologies to improve early detection and monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease Advancing ultrasound technologies that are safer, more accessible alternatives to invasive diagnostic procedures Research led by globally respected hepatologist Associate Professor Dan Yock Young SINGAPORE, Oct. 8, 2025 -- Siemens Healthineers and the National University Hospital (NUH) Singapore have announced a strategic research collaboration to advance diagnostic solutions for Metabolic Dysfunction-Associat
- 김갑성 기자
- 2025-10-08 11:15

이전

11 12 13 14 15 16 17 18 19 20

많이 본 기사

최근기사

2025-10-19_SUN

2025-10-18_SAT

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 10월 19일 03시 20분